| Id |
Subject |
Object |
Predicate |
Lexical cue |
| TextSentencer_T1 |
0-178 |
Sentence |
denotes |
Blood group glycosphingolipid expression in kidney of an individual with the rare blood group A1 Le(a-b+) p phenotype: absence of blood group structures based on the globoseries. |
| T1 |
0-178 |
Sentence |
denotes |
Blood group glycosphingolipid expression in kidney of an individual with the rare blood group A1 Le(a-b+) p phenotype: absence of blood group structures based on the globoseries. |
| TextSentencer_T2 |
179-333 |
Sentence |
denotes |
Total neutral glycolipid fractions were isolated from kidney and ureter tissue obtained at autopsy of an individual of the rare blood group A1 Le(a-b+) p. |
| T2 |
179-333 |
Sentence |
denotes |
Total neutral glycolipid fractions were isolated from kidney and ureter tissue obtained at autopsy of an individual of the rare blood group A1 Le(a-b+) p. |
| TextSentencer_T3 |
334-502 |
Sentence |
denotes |
The amount of glycolipids isolated were 3.7 and 2.5 mg g-1 dry tissue weight for the kidney and ureter tissue, which is in the range of reference blood group P kidneys. |
| T3 |
334-502 |
Sentence |
denotes |
The amount of glycolipids isolated were 3.7 and 2.5 mg g-1 dry tissue weight for the kidney and ureter tissue, which is in the range of reference blood group P kidneys. |
| TextSentencer_T4 |
503-570 |
Sentence |
denotes |
Part of the kidney glycolipid fraction was subfractionated by HPLC. |
| T4 |
503-570 |
Sentence |
denotes |
Part of the kidney glycolipid fraction was subfractionated by HPLC. |
| TextSentencer_T5 |
571-767 |
Sentence |
denotes |
Glycolipid compounds were structurally characterized by thin-layer chromatography (chemical detection and immunostaining with monoclonal antibodies), proton NMR spectroscopy and mass spectrometry. |
| T5 |
571-767 |
Sentence |
denotes |
Glycolipid compounds were structurally characterized by thin-layer chromatography (chemical detection and immunostaining with monoclonal antibodies), proton NMR spectroscopy and mass spectrometry. |
| TextSentencer_T6 |
768-987 |
Sentence |
denotes |
Globotriaosyl- and globotetraosyl-ceramides, which are the major compounds in kidneys of P individuals, were absent in the p kidney, and a comparatively increased amount of monoglycosyl- and lactosylceramides was found. |
| T6 |
768-987 |
Sentence |
denotes |
Globotriaosyl- and globotetraosyl-ceramides, which are the major compounds in kidneys of P individuals, were absent in the p kidney, and a comparatively increased amount of monoglycosyl- and lactosylceramides was found. |
| TextSentencer_T7 |
988-1076 |
Sentence |
denotes |
A shift to longer fatty acyl chains in the ceramide part of lactosylceramides was noted. |
| T7 |
988-1076 |
Sentence |
denotes |
A shift to longer fatty acyl chains in the ceramide part of lactosylceramides was noted. |
| TextSentencer_T8 |
1077-1209 |
Sentence |
denotes |
Elongated globoseries compounds with five to seven sugar residues, including the blood group A type 4 chain structure, were lacking. |
| T8 |
1077-1209 |
Sentence |
denotes |
Elongated globoseries compounds with five to seven sugar residues, including the blood group A type 4 chain structure, were lacking. |
| TextSentencer_T9 |
1210-1304 |
Sentence |
denotes |
A slight increase in neolactotetraosyl- and blood group X pentaglycosyl-ceramides was noticed. |
| T9 |
1210-1304 |
Sentence |
denotes |
A slight increase in neolactotetraosyl- and blood group X pentaglycosyl-ceramides was noticed. |
| TextSentencer_T10 |
1305-1486 |
Sentence |
denotes |
The study confirms an enzymatic block in the conversion of lactosylceramide to elongated globoseries compounds in the kidney tissue similar to that of erythrocytes of p individuals. |
| T10 |
1305-1486 |
Sentence |
denotes |
The study confirms an enzymatic block in the conversion of lactosylceramide to elongated globoseries compounds in the kidney tissue similar to that of erythrocytes of p individuals. |